These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11241410

  • 1. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma.
    de Jong D, Vyth-Dreese F, Dellemijn T, Verra N, Ruskoné-Fourmestraux A, Lavergne-Slove A, Hart G, Boot H.
    J Pathol; 2001 Mar; 193(3):318-24. PubMed ID: 11241410
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 3. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C.
    Haematologica; 2001 Jun 21; 86(6):609-17. PubMed ID: 11418369
    [Abstract] [Full Text] [Related]

  • 4. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y, Kinoshita Y, Fukui H, Maekawa T, Yazumi S, Okada A, Nakase H, Kawanami C, Iwano M, Hashimoto K, Takeda Z, Okazaki K, Chiba T.
    J Gastroenterol; 2002 Jun 21; 37(6):428-33. PubMed ID: 12108676
    [Abstract] [Full Text] [Related]

  • 5. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, de Mascarel A, Hemery F, Gaulard P, Delchier JC, Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Am J Gastroenterol; 2002 Feb 21; 97(2):292-7. PubMed ID: 11866264
    [Abstract] [Full Text] [Related]

  • 6. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G, Martínez Egea A, Sánchez Cuenca J, Onrubia Pintado J, García Lafuente N, Ruiz Gómez F, Coronas Planas M.
    Rev Esp Enferm Dig; 1999 Aug 21; 91(8):541-8. PubMed ID: 10491486
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Frutos B, Calleja JL, Sánchez-Godoy P, Bellas C.
    Med Clin (Barc); 1998 Jan 24; 110(2):41-4. PubMed ID: 9534129
    [Abstract] [Full Text] [Related]

  • 8. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.
    Am J Gastroenterol; 2008 Jan 24; 103(1):62-70. PubMed ID: 17894851
    [Abstract] [Full Text] [Related]

  • 9. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH, Chen LT, Wu MS, Kuo KT, Yeh KH, Doong SL, Yeh PY, Hsu HC, Tzeng YS, Lin CW, Lin JT, Cheng AL.
    J Pathol; 2007 Feb 24; 211(3):296-304. PubMed ID: 17167822
    [Abstract] [Full Text] [Related]

  • 10. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M.
    Cancer; 2005 Aug 01; 104(3):532-40. PubMed ID: 15937928
    [Abstract] [Full Text] [Related]

  • 11. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A, Miedico A, Tedeschi L, Patti C, Di Raimondo F, Leone M, Schinocca L, Romanelli A, Bonanno G, Linea C, Giustini M, Hassan C, Cottone M, Zullo A.
    Dig Liver Dis; 2009 Jul 01; 41(7):467-73. PubMed ID: 18945654
    [Abstract] [Full Text] [Related]

  • 12. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS, Jung HY, Choi KD, Song HJ, Lee GH, Oh TH, Jo JY, Kim KJ, Byeon JS, Myung SJ, Yang SK, Hong WS, Kim JH, Min YI.
    Helicobacter; 2006 Dec 01; 11(6):569-73. PubMed ID: 17083379
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
    Vrieling C, de Jong D, Boot H, de Boer JP, Wegman F, Aleman BM.
    Radiother Oncol; 2008 Jun 01; 87(3):405-11. PubMed ID: 18343513
    [Abstract] [Full Text] [Related]

  • 14. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected.
    Chang DK, Chin YJ, Kim JS, Jung HC, Kim CW, Song IS, Kim CY.
    Hepatogastroenterology; 1999 Jun 01; 46(28):2694-700. PubMed ID: 10522067
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS, Chung SJ, Choi YS, Cheon JH, Kim CW, Kim SG, Jung HC, Song IS.
    Br J Cancer; 2007 May 07; 96(9):1324-8. PubMed ID: 17406363
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N, Chiba T, Origasa H, Asaka M, JAPAN GAST Study Group.
    Gut; 2012 Apr 07; 61(4):507-13. PubMed ID: 21890816
    [Abstract] [Full Text] [Related]

  • 17. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
    Delchier JC.
    Gastroenterol Clin Biol; 2003 Mar 07; 27(3 Pt 2):453-8. PubMed ID: 12700502
    [Abstract] [Full Text] [Related]

  • 18. [MALT-type low-grade B-cell lymphomas of the stomach and Helicobacter pylori].
    Binek J, Morant R, Weber A, Schmid U, Hammer B.
    Schweiz Med Wochenschr; 1996 May 11; 126(19):841-4. PubMed ID: 8693310
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, Deforges L, Chaumette MT, Haioun C.
    Am J Gastroenterol; 2001 Aug 11; 96(8):2324-8. PubMed ID: 11513169
    [Abstract] [Full Text] [Related]

  • 20. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
    Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wündisch T, Neubauer A, Raderer M, Savio A, EGILS (European Gastro-Intestinal Lymphoma Study) Group.
    Gut; 2007 Dec 11; 56(12):1685-7. PubMed ID: 17639089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.